Added 7 days ago Drug news

TOUR study of Vibativ reports use in S. aureus infections in real world setting.- Theravance Biopharma.

Theravance Biopharma announced that positive new data from multiple studies of Vibativ (telavancin) in treating infection from the ongoing Telavancin...

Added 10 days ago Drug news

Real-world registry data for Orbactiv in ABSSSI published in Open Forum Infectious Diseases.- Melinta Therapeutics.

Melinta Therapeutics announced that findings from the first phase of the ongoing Clinical and Historic Registry and Orbactiv Medical Evaluation...

Added 11 days ago Drug news

Novartis agrees licence of early stage antibiotics to Boston Pharmaceuticals.

Novartis announced that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three...

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 2 years ago

The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 6 years ago

Fever in under 5s: assessment and initial management

This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5.

Added 5 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 8 months ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 1 year ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 1 year ago